Status:
TERMINATED
Arithmetic Abilities in Children With 22q11.2DS
Lead Sponsor:
Hôpital le Vinatier
Conditions:
22q11.2 Deletion Syndrome
Eligibility:
All Genders
4-11 years
Phase:
NA
Brief Summary
The study ARITH22 will investigate the role of visuo-spatial attention on arithmetic abilities of children with 22q11.2 deletion syndrome.
Detailed Description
Children with 22q11.2 deletion syndrome often have arithmetic learning disability because of magnitude representation impairment. Previous works suggested that magnitude representation impairment coul...
Eligibility Criteria
Inclusion
- Diagnosis of 22q11.2 deletion syndrome or no developmental disease
- Aged from 4 to 11 years old
- French language
Exclusion
- Diagnosis of intellectual deficiency according to DSM 5 criteria
- Drug prescribed for somatic condition that could influence cerebral functioning
Key Trial Info
Start Date :
September 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 14 2023
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT04373226
Start Date
September 16 2020
End Date
April 14 2023
Last Update
March 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Vinatier
Lyon, Auvergne-Rhône-Alpes, France, 69678